Every growing niche accumulates myths faster than facts. The six most common, audited:
False, with a true core. 30–50% resorbs in the early months — that's the honest arithmetic, planned for with modest over-correction. The 50–70% that gains blood supply is permanent living tissue. "All dies" and "all stays" are both marketing; the percentage is medicine.
False. Different goal (lateral smoothing vs global projection), different volumes (hundreds of cc vs litres), different planes emphasis, opposite recovery rules (side-lying banned vs sitting banned). Calling it a mini BBL is how patients get quoted for surgery they didn't request.
Misleading. The week-one preview is swelling plus over-correction — bigger than your result. The real answer arrives at months 3–6. Judging early in either direction is judging the wrong thing.
False, and this site's founding correction. Bone geometry isn't trainable; gluteus medius lives above and behind the hollow. No programme was going to work — including the one being sold under this myth.
Half-false. Filler fills — temporarily (1–3 years), at per-cc pricing that overtakes surgery across renewal cycles, with lump and migration risks that grow at hip volumes. For small refinements it's rational; "the same thing" it is not.
Opposite of the evidence. Done honestly — modest volumes smoothing your own line — the result reads as "you, in better proportions." The tell isn't the surgery; it's over-correction, which the volume ceilings here exist to prevent. The best outcomes are the ones nobody can name.
Heard a claim not on this list? Send it over — auditing myths is cheaper than absorbing them.
